The Innovation That Targets Cancer at the Molecular Level
Precision Imaging + Targeted Radionuclide Therapy
Our advanced molecular approach uses radioactive isotopes attached to targeted molecules to seek out cancer cells anywhere in the body.
This combination delivers: unparalleled diagnostic clarity PLUS systemic, targeted destruction of cancer cells. This "theranostic" approach—seeing what we treat and treating what we see—is what makes Makis Health Clinic's approach uniquely effective.
MOLECULAR IMAGING
Precision Diagnostics
Utilizing state-of-the-art PET/CT scans to map the exact location and extent of disease at the molecular level.
Targeted Radiotracers
We use specialized radiotracers to
identify specific receptors on your cancer cells, illuminating hidden metastases.
TARGETED THERAPY
Radionuclide Delivery
Therapeutic isotopes are administered systemically, binding exclusively to the cancer cells identified during imaging, delivering a high dose of radiation directly to the tumor.
THE INNOVATION
Theranostics
By pairing diagnostic imaging with corresponding targeted therapy, we ensure that the treatment goes exactly where it is needed, minimizing damage to surrounding healthy tissues and effectively treating systemic disease.
About Us
At Makis Health Clinic, we elevate cancer care through the power of nuclear medicine and theranostics.
You don't have to abandon your current oncologist or treatment plan— our molecular approach is designed to complement existing therapies by providing unmatched diagnostic clarity and highly targeted treatment options. Each treatment is precisely tailored to the unique molecular signature of your cancer, ensuring that your care plan is as specific as your disease. We map the cancer accurately and attack it directly at the cellular level.
Read MorePrecision-First Diagnostics
Every diagnosis begins with molecular imaging to map the cancer at the cellular level before any treatment decision is made.
Targeted, Systemic Treatment
Therapeutic isotopes travel systemically to bind exclusively to cancer cells — treating disease wherever it exists in the body.
Integrative, Complementary Care
Our approach is designed to work alongside your existing oncologist and treatment plan — not replace it.
Harnessing Radioisotopes to Fight Cancer Systemically
Molecular imaging reveals the hidden spread of cancer. By replacing the diagnostic isotope with a therapeutic one, we transform a scan into a targeted weapon. The radioactive molecules travel through the bloodstream, finding and binding to cancer cells wherever they are, delivering radiation locally to the tumor while preserving healthy cells.
Why Targeted Radionuclide Therapy?
Treating the cancer, sparing the patient
Traditional radiation therapy applies radiation from outside the body, which can affect healthy tissues in the crossfire. Targeted radionuclide therapy is fundamentally different: the radiation is delivered systemically but acts locally. The radioactive molecules are designed to only stick to cancer cells.
If the PET scan shows that the cancer cells have the specific receptors, we know with high certainty that the therapeutic dose will reach its target. This "see it, treat it" paradigm offers unprecedented precision in modern oncology.
Key Advantages
- Radiation is delivered directly to cancer cells at a molecular level
- Significantly reduces damage to surrounding healthy tissue
- Effectively treats widespread metastatic disease
- Theranostic approach confirms target engagement before treatment
Procedures & Diagnostics
At Makis Health Clinic, we utilize advanced nuclear medicine techniques to accurately map and aggressively treat cancer. Our team will guide you every step of the way to determine if you are a candidate for targeted radionuclide therapy.
Advanced PET/CT Imaging
We utilize highly specific radiotracers (like PSMA, DOTATATE, or FDG) in conjunction with high-resolution PET/CT scanners to identify the exact location and metabolic activity of cancer cells.
Read More →Lutetium-177 (Lu-177) Therapy
A targeted radionuclide therapy often used for advanced prostate cancer (Lu-177 PSMA) and neuroendocrine tumors (Lu-177 DOTATATE). It delivers beta radiation directly to the tumor cells.
Read More →Targeted Alpha Therapy (TAT)
An emerging treatment using alpha-emitting isotopes (such as Actinium-225) attached to cancer-targeting molecules. Alpha particles deliver immense energy over microscopic distances, obliterating cancer cells.
Read More →Theranostic Consultations
Comprehensive evaluations to determine if your specific tumor expresses the necessary receptors for targeted radionuclide therapies.
Read More →Radium-223 Therapy
A targeted alpha therapy specifically designed to treat bone metastases in patients with advanced prostate cancer, mimicking calcium to directly target bone lesions.
Read More →Standard Of Care Plus
A holistic approach that combines standard oncology treatments with advanced nuclear medicine diagnostics and theranostics.
Read More →Featured Supplements
High-quality, practitioner-grade supplements carefully selected to support your journey to optimal health.
Our Testimonials
Discover the impact our targeted radionuclide therapies have had in the lives of our patients. Hear from those who have experienced the precise diagnostics and innovative treatments at Makis Health Clinic.
View All Testimonials →Meet Dr. William Makis
MD, FRCPC | Expert in Nuclear Medicine & PET/CT Imaging
Dr. William Makis is a highly experienced physician specializing in Nuclear Medicine and Targeted Radionuclide Therapy. With a strong background in molecular imaging, he has dedicated his career to advancing diagnostic accuracy and precision oncology.
He is the author of "The Nuclear Medicine Frontier" and has contributed to numerous peer-reviewed publications shaping the future of targeted cancer treatments.
Read Dr. Makis' Full BioReady to Take Control of Your Cancer Journey?
Contact us today to schedule a consultation and learn if you are a candidate for our advanced targeted radionuclide therapies.
Make an Appointment Today